The magnitude of OS benefit with upfront HDT is cytogenetics-dependent. Patients with high-risk cytogenetics should preferably receive upfront rather...
This makes an interdisciplinary approach mandatory for the management of these patients, to provide the best care possible based on tumor size, site...